Login / Signup

Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.

Shari B BrosnahanXian Jie Cindy ChengJuri ChungDiana AltshulerShahidul IslamSarun V ThomasMegan D WinnerAllison A GrecoJasmin DiversPeter SpieglerDaniel H StermanSam Parnia
Published in: The Annals of pharmacotherapy (2021)
Combination of tocilizumab and corticosteroids was associated with improved 28-day survival when compared with corticosteroids alone. Modification of steroid dosing strategy as well as steroid type may further optimize therapeutic effect of the COVID-19 treatment.
Keyphrases